Packaging contractor Helvoet places stake in Asia; Merck, Emergent add staff;

> Belgium-based parenterals packager Helvoet Pharma is building a $26.5 million plant in India, expected to open in 2012, to establish an Asian presence. Story

> Merck has been adding staff to its vaccine manufacturing plant in Durham, NC, and expects to hire an additional 310 people over the next two years. Article

> Maryland-based Emergent Biosolutions continues to grow in Lansing, MI, as it ramps up production for its anthrax vaccine. News

> European CMO NextPharma says it has passed an inspection by Japanese regulator PMDA resulting in continued accreditation of its Brussels-area Braine-l'Alleud facility, used in aseptic production and the manufacture of cytotoxic products. Article

> Meridian Life Science of Memphis has completed a second clinical cGMP production lot of the live oral RV3 rotavirus vaccine candidate. Report

> Reliable Biopharmaceutical in St. Louis has named David Feldker its CEO and president, effective next month. Reliable release


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.